10-Q · 2026-11-09
Whitehawk Therapeutics releases its Q3 2026 financial results, showcasing key metrics and ongoing projects in the pharmaceutical sector.
| Name | Whitehawk Therapeutics, Inc. |
|---|---|
| CIK | 0001422142 |
| Tickers | WHWK |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 611547850 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 551-321-2234 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Whitehawk Therapeutics releases its Q3 2026 financial results, showcasing key metrics and ongoing projects in the pharmaceutical sector.
Whitehawk Therapeutics announces its financial results for Q3 2026, highlighting its position in the pharmaceutical preparations industry.
676 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-052436 | 005-83932 | 261561750 | 34 | 20036 | |||
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001943462-26-000010 | 005-83932 | 261556705 | 34 | 74543 | |||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-127421 | 005-83932 | 261554963 | 34 | 18543 | |||
| 2026-11-09 | 10-Q | 10-Q | 0001193125-26-453576 | 001-38560 | 261535940 | 34 | 12642216 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-452704 | 001-38560 | 261533904 | 34 | 642722 | 1 | 1 |
| 2026-09-18 | 4/A | xslF345X06/form4a-09182026_080953.xml | 0001754154-26-000016 | 9284 | ||||||
| 2026-09-18 | 4/A | xslF345X06/form4a-09182026_080958.xml | 0001766522-26-000017 | 9245 | ||||||
| 2026-09-18 | 4/A | xslF345X06/form4a-09182026_080955.xml | 0001821353-26-000007 | 9244 | ||||||
| 2026-09-18 | 4/A | xslF345X06/form4a-09182026_080949.xml | 0001995275-26-000018 | 9270 | ||||||
| 2026-09-18 | 4/A | xslF345X06/form4a-09182026_080933.xml | 0001909734-26-000011 | 9278 | ||||||
| 2026-09-15 | 4 | xslF345X06/form4-09152026_110953.xml | 0001995275-26-000016 | 9242 | ||||||
| 2026-09-15 | 4 | xslF345X06/form4-09152026_110910.xml | 0001754154-26-000014 | 9256 | ||||||
| 2026-09-15 | 4 | xslF345X06/form4-09152026_110928.xml | 0001909734-26-000009 | 9250 | ||||||
| 2026-09-15 | 4 | xslF345X06/form4-09152026_110942.xml | 0001821353-26-000005 | 9216 | ||||||
| 2026-09-15 | 4 | xslF345X06/form4-09152026_110959.xml | 0001766522-26-000015 | 9217 | ||||||
| 2026-09-11 | 4 | xslF345X06/form4-09112026_080943.xml | 0001670000-26-000008 | 6282 | ||||||
| 2026-09-11 | 3 | xslF345X06/form3-09112026_080942.xml | 0001670000-26-000007 | 10254 | ||||||
| 2026-09-10 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-388010 | 001-38560 | 261371867 | 34 | 168370 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000947871-26-000805 | 005-83932 | 261284079 | 34 | 17255 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-038432 | 005-83932 | 261282452 | 34 | 25557 | |||
| 2026-08-06 | 10-Q | 10-Q | 0001193125-26-337933 | 001-38560 | 261248783 | 34 | 11672680 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-337069 | 001-38560 | 261246846 | 34 | 629078 | 1 | 1 |
| 2026-07-30 | 4 | xslF345X06/form4-07302026_080728.xml | 0001602474-26-000004 | 9233 | ||||||
| 2026-06-15 | 4 | xslF345X06/form4-06152026_090634.xml | 0002049287-26-000003 | 6253 | ||||||
| 2026-06-15 | 4 | xslF345X06/form4-06152026_090628.xml | 0001680329-26-000005 | 6235 | ||||||
| 2026-06-15 | 4 | xslF345X06/form4-06152026_090617.xml | 0001364590-26-000003 | 6260 | ||||||
| 2026-06-15 | 4 | xslF345X06/form4-06152026_090619.xml | 0001654482-26-000003 | 6247 | ||||||
| 2026-06-15 | 4 | xslF345X06/form4-06152026_090610.xml | 0001878692-26-000003 | 6248 | ||||||
| 2026-06-15 | 4 | xslF345X06/form4-06152026_090621.xml | 0001355758-26-000007 | 6252 | ||||||
| 2026-06-15 | 4 | xslF345X06/form4-06152026_090652.xml | 0001701815-26-000006 | 10762 | ||||||
| 2026-06-12 | 8-K | 8-K | 5.07 | 0001193125-26-269493 | 001-38560 | 261086988 | 34 | 171438 | 1 | 1 |
| 2026-06-09 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001932 | 333-296353 | 261077895 | 33 | 2106 | ||
| 2026-06-05 | CORRESP | filename1.htm | 0001193125-26-259538 | 7838 | ||||||
| 2026-06-05 | UPLOAD | filename1.pdf | 0000000000-26-005723 | 333-296353 | 151663 | |||||
| 2026-05-29 | S-3 | S-3 | 0001193125-26-248349 | 333-296353 | 261044718 | 33 | 573636 | 1 | 1 | |
| 2026-05-21 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-234890 | 001-38560 | 261009905 | 34 | 171954 | 1 | 1 |
| 2026-05-18 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000935836-26-000289 | 005-83932 | 26995462 | 34 | 23669 | |||
| 2026-05-18 | 4 | xslF345X06/form4-05182026_080531.xml | 0001909734-26-000005 | 5153 | ||||||
| 2026-05-18 | 4 | xslF345X06/form4-05182026_080529.xml | 0001766522-26-000013 | 5121 | ||||||
| 2026-05-18 | 4 | xslF345X06/form4-05182026_080534.xml | 0001754154-26-000012 | 5154 | ||||||
| 2026-05-18 | 4 | xslF345X06/form4-05182026_080535.xml | 0001995275-26-000014 | 5140 | ||||||
| 2026-05-18 | 4 | xslF345X06/form4-05182026_080536.xml | 0001355758-26-000003 | 9152 | ||||||
| 2026-05-14 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000902664-26-002450 | 005-83932 | 26981492 | 34 | 17991 | |||
| 2026-05-14 | 4 | xslF345X06/ownership.xml | 0000902664-26-002449 | 11816 | ||||||
| 2026-05-13 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-26-220656 | 001-38560 | 26971012 | 34 | 806278 | 1 | 1 |
| 2026-05-07 | 10-Q | 10-Q | 0001193125-26-212075 | 001-38560 | 26953941 | 34 | 10250722 | 1 | 1 | |
| 2026-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-210615 | 001-38560 | 26951191 | 34 | 535880 | 1 | 1 |
| 2026-04-28 | DEFA14A | DEFA14A | 0001193125-26-187189 | 001-38560 | 26908228 | 34 | 3247528 | 1 | 1 | |
| 2026-04-28 | ARS | ARS | 0001193125-26-187156 | 001-38560 | 26908172 | 34 | 4311163 | |||
| 2026-04-28 | DEF 14A | DEF 14A | 0001193125-26-187149 | 001-38560 | 26908150 | 34 | 13470174 | 1 | 1 | |
| 2026-04-17 | 4 | xslF345X06/form4-04172026_080413.xml | 0001754154-26-000010 | 7145 | ||||||
| 2026-04-15 | 144 | xsl144X01/primary_doc.xml | 0001754154-26-000007 | 001-38560 | 26865340 | 33 | 5450 | |||
| 2026-04-15 | 4 | xslF345X06/form4-04152026_110455.xml | 0001766522-26-000011 | 6900 | ||||||
| 2026-04-13 | 4 | xslF345X06/form4-04142026_120420.xml | 0001766522-26-000009 | 6899 | ||||||
| 2026-04-10 | 4 | xslF345X06/form4-04102026_100459.xml | 0001995275-26-000012 | 5374 | ||||||
| 2026-04-09 | 144 | xsl144X01/primary_doc.xml | 0001766522-26-000007 | 001-38560 | 26852921 | 33 | 5360 | |||
| 2026-04-09 | 144 | xsl144X01/primary_doc.xml | 0001995275-26-000011 | 001-38560 | 26852870 | 33 | 8246 | |||
| 2026-04-08 | 4 | xslF345X06/form4-04092026_120451.xml | 0001995275-26-000008 | 8396 | ||||||
| 2026-04-03 | 4 | xslF345X06/form4-04032026_100433.xml | 0001821353-26-000003 | 6376 | ||||||
| 2026-04-03 | 4 | xslF345X06/form4-04032026_100421.xml | 0001909734-26-000003 | 6410 | ||||||
| 2026-04-03 | 4 | xslF345X06/form4-04032026_100426.xml | 0001766522-26-000005 | 10569 | ||||||
| 2026-04-03 | 4 | xslF345X06/form4-04032026_100439.xml | 0001754154-26-000005 | 10568 | ||||||
| 2026-04-03 | 4 | xslF345X06/form4-04032026_100411.xml | 0001995275-26-000006 | 12256 | ||||||
| 2026-04-02 | 144 | xsl144X01/primary_doc.xml | 0001995275-26-000005 | 001-38560 | 26836641 | 33 | 5499 | |||
| 2026-03-12 | S-8 | S-8 | 0001193125-26-104333 | 333-294256 | 26748595 | 33 | 236986 | 1 | 1 | |
| 2026-03-12 | 10-K | 10-K | 0001193125-26-104158 | 001-38560 | 26747838 | 34 | 19169014 | 1 | 1 | |
| 2026-03-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-103117 | 001-38560 | 26745704 | 34 | 612230 | 1 | 1 |
| 2026-03-10 | 4 | xslF345X05/form4-03102026_110350.xml | 0001995275-26-000002 | 9545 | ||||||
| 2026-03-10 | 4 | xslF345X05/form4-03102026_110300.xml | 0001754154-26-000002 | 9556 | ||||||
| 2026-03-10 | 4 | xslF345X05/form4-03102026_110307.xml | 0001766522-26-000002 | 9559 | ||||||
| 2025-12-02 | 4 | xslF345X05/form4-12022025_091222.xml | 0001909734-25-000006 | 9112 | ||||||
| 2025-12-02 | 3 | xslF345X02/form3-12022025_091232.xml | 0001909734-25-000005 | 10212 | ||||||
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-268895 | 001-38560 | 251457387 | 34 | 12476304 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-268134 | 001-38560 | 251456266 | 34 | 627074 | 1 | 1 |
| 2025-08-25 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-003766 | 005-83932 | 251251317 | 34 | 15892 | |||
| 2025-08-07 | 10-Q | 10-Q | 0000950170-25-105081 | 001-38560 | 251194507 | 34 | 12346250 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-104592 | 001-38560 | 251191725 | 34 | 621816 | 1 | 1 |
| 2025-06-17 | 4 | xslF345X05/form4-06182025_120641.xml | 0001415889-25-017620 | 6065 | ||||||
| 2025-06-17 | 4 | xslF345X05/form4-06172025_080628.xml | 0001415889-25-017547 | 12728 | ||||||
| 2025-06-16 | 4 | xslF345X05/form4-06162025_080632.xml | 0001415889-25-017412 | 13222 | ||||||
| 2025-06-16 | 4 | xslF345X05/form4-06162025_080629.xml | 0001415889-25-017411 | 13231 | ||||||
| 2025-06-16 | 4 | xslF345X05/form4-06162025_080636.xml | 0001415889-25-017410 | 13197 | ||||||
| 2025-06-16 | 4 | xslF345X05/form4-06162025_080636.xml | 0001415889-25-017409 | 13224 | ||||||
| 2025-06-16 | 4 | xslF345X05/form4-06162025_080639.xml | 0001415889-25-017407 | 13173 | ||||||
| 2025-06-16 | 4 | xslF345X05/form4-06162025_080637.xml | 0001415889-25-017406 | 17610 | ||||||
| 2025-06-13 | 8-K | 8-K | 5.07 | 0001193125-25-140810 | 001-38560 | 251047233 | 34 | 152716 | 1 | 1 |
| 2025-05-22 | UPLOAD | filename1.pdf | 0000000000-25-005482 | 001-38560 | 40048 | |||||
| 2025-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000947871-25-000540 | 005-83932 | 25956417 | 34 | 15438 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-002376 | 005-83932 | 25952161 | 34 | 12588 | |||
| 2025-05-13 | CORRESP | filename1.htm | 0001193125-25-119011 | 21173 | ||||||
| 2025-05-08 | 10-Q | 10-Q | 0001628280-25-023932 | 001-38560 | 25927539 | 34 | 7832375 | 1 | 1 | |
| 2025-05-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-023788 | 001-38560 | 25926074 | 34 | 259546 | 1 | 1 |
| 2025-05-07 | UPLOAD | filename1.pdf | 0000000000-25-004861 | 001-38560 | 42747 | |||||
| 2025-04-28 | ARS | ARS | 0001193125-25-100734 | 001-38560 | 25881236 | 34 | 21550692 | |||
| 2025-04-28 | DEFA14A | DEFA14A | 0001628280-25-020317 | 001-38560 | 25880946 | 34 | 383165 | |||
| 2025-04-28 | DEF 14A | DEF 14A | 0001628280-25-020311 | 001-38560 | 25880909 | 34 | 3837772 | 1 | 1 | |
| 2025-04-25 | 424B5 | 424B5 | 0001193125-25-097064 | 333-277018 | 25874942 | 33 | 387829 | |||
| 2025-04-08 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001044 | 333-286284 | 25823449 | 33 | 2105 | ||
| 2025-04-04 | CORRESP | filename1.htm | 0001193125-25-073631 | 8994 | ||||||
| 2025-04-04 | UPLOAD | filename1.pdf | 0000000000-25-003667 | 333-286284 | 40454 | |||||
| 2025-04-03 | 4 | xslF345X05/form4-04032025_110433.xml | 0001415889-25-010080 | 8916 | ||||||
| 2025-04-03 | 4 | xslF345X05/form4-04032025_110445.xml | 0001415889-25-010079 | 8867 | ||||||
| 2025-04-03 | 4 | xslF345X05/form4-04032025_110406.xml | 0001415889-25-010076 | 8901 | ||||||
| 2025-03-31 | S-3 | S-3 | 0001193125-25-068942 | 333-286284 | 25795271 | 33 | 866606 | |||
| 2025-03-31 | 8-K/A | 8-K/A | 9.01 | 0001193125-25-068845 | 001-38560 | 25794515 | 34 | 242786 | 1 | 1 |
| 2025-03-28 | S-8 | S-8 | 0001193125-25-067200 | 333-286229 | 25787293 | 33 | 90524 | |||
| 2025-03-28 | 10-K | 10-K | 0001628280-25-015269 | 001-38560 | 25780795 | 34 | 22159589 | 1 | 1 | |
| 2025-03-26 | 8-K | 8-K | 2.01,9.01 | 0001193125-25-063253 | 001-38560 | 25770268 | 34 | 150223 | 1 | 1 |
| 2025-03-18 | 8-K | 8-K | 2.02,5.03,9.01 | 0001193125-25-056708 | 001-38560 | 25749020 | 34 | 531871 | 1 | 1 |
| 2025-03-18 | D | xslFormDX01/primary_doc.xml | 06b | 0002018445-25-000002 | 021-541194 | 25746698 | 33 | 17422 | ||
| 2025-03-11 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-001906 | 005-83932 | 25729521 | 34 | 18960 | |||
| 2025-03-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-25-009710 | 005-83932 | 25724169 | 34 | 73131 | |||
| 2025-03-06 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000950170-25-034969 | 005-83932 | 25716647 | 34 | 8524 | |||
| 2025-03-05 | 4 | xslF345X05/form4-03062025_120354.xml | 0001415889-25-007096 | 6346 | ||||||
| 2025-03-05 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001373604-25-000045 | 005-83932 | 25710750 | 34 | 17202 | |||
| 2025-03-04 | 4 | xslF345X05/form4-03052025_120307.xml | 0001415889-25-006742 | 5851 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_110310.xml | 0001415889-25-006682 | 4994 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_110311.xml | 0001415889-25-006678 | 6111 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_110346.xml | 0001415889-25-006676 | 17507 | ||||||
| 2025-03-04 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000902664-25-001335 | 005-83932 | 25707072 | 34 | 14847 | |||
| 2025-03-04 | 4 | xslF345X05/ownership.xml | 0000902664-25-001334 | 11391 | ||||||
| 2025-03-04 | 8-K | 8-K | 1.01,5.07,7.01,9.01 | 0001193125-25-045605 | 001-38560 | 25704636 | 34 | 462657 | 1 | 1 |
| 2025-03-03 | 4 | xslF345X05/form4-03042025_010336.xml | 0001415889-25-006318 | 15992 | ||||||
| 2025-03-03 | 4 | xslF345X05/form4-03042025_010346.xml | 0001415889-25-006316 | 9407 | ||||||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0001786205-25-000024 | 001-38560 | 25701005 | 33 | 4676 | |||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0001786205-25-000023 | 001-38560 | 25700999 | 33 | 4578 | |||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0001786205-25-000022 | 001-38560 | 25700987 | 33 | 4546 | |||
| 2025-02-24 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001373604-25-000038 | 005-83932 | 25655207 | 34 | 17060 | |||
| 2025-02-19 | DEFA14A | DEFA14A | 0001193125-25-029692 | 001-38560 | 25641574 | 34 | 29866 | |||
| 2025-02-18 | 3 | xslF345X02/form3-02182025_090217.xml | 0001415889-25-004450 | 10060 | ||||||
| 2025-02-18 | DEFA14A | DEFA14A | 0001193125-25-028632 | 001-38560 | 25635237 | 34 | 40152 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895345-25-000071 | 005-83932 | 25630500 | 34 | 6217 | |||
| 2025-02-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-020936 | 005-83932 | 25626483 | 34 | 7023 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000935836-25-000158 | 005-83932 | 25625520 | 34 | 16083 | |||
| 2025-02-05 | DEFA14A | DEFA14A | 0001193125-25-020865 | 001-38560 | 25594034 | 34 | 38089 | |||
| 2025-02-04 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001373604-25-000005 | 005-83932 | 25586116 | 34 | 42227 | |||
| 2025-01-31 | DEFM14A | DEFM14A | 0001193125-25-018470 | 001-38560 | 25579373 | 34 | 10200255 | |||
| 2025-01-30 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001373604-25-000003 | 005-83932 | 25573334 | 34 | 22382 | |||
| 2025-01-29 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000547 | 005-83932 | 25570638 | 34 | 17518 | |||
| 2025-01-24 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000935836-25-000082 | 005-83932 | 25553634 | 34 | 24592 | |||
| 2025-01-21 | PREM14A | PREM14A | 0001193125-25-009599 | 001-38560 | 25543121 | 34 | 9831759 | |||
| 2024-12-31 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001373604-24-000118 | 005-83932 | 241591665 | 34 | 16540 | |||
| 2024-12-30 | DEFA14A | DEFA14A | 0001193125-24-286907 | 001-38560 | 241590488 | 34 | 60835 | |||
| 2024-12-23 | 4 | xslF345X05/form4-12232024_101210.xml | 0001415889-24-030096 | 6033 | ||||||
| 2024-12-23 | 3 | xslF345X02/form3-12232024_101253.xml | 0001415889-24-030095 | 10026 | ||||||
| 2024-12-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000950170-24-139724 | 005-83932 | 241575000 | 34 | 20235 | |||
| 2024-12-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000902664-24-007000 | 005-83932 | 241573403 | 34 | 16974 | |||
| 2024-12-20 | DEFA14A | DEFA14A | 0001193125-24-282417 | 001-38560 | 241564973 | 34 | 4720369 | |||
| 2024-12-20 | 8-K | 8-K | 1.01,3.02,5.02,7.01,9.01 | 0001193125-24-282407 | 001-38560 | 241564953 | 34 | 5175263 | 1 | 1 |
| 2024-11-06 | 10-Q | 10-Q | 0001628280-24-045698 | 001-38560 | 241430963 | 34 | 7739353 | 1 | 1 | |
| 2024-11-06 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-045465 | 001-38560 | 241429309 | 34 | 263172 | 1 | 1 |
| 2024-10-03 | 4 | xslF345X05/form4-10032024_111036.xml | 0001415889-24-024676 | 15664 | ||||||
| 2024-10-03 | 144 | xsl144X01/primary_doc.xml | 0001995275-24-000003 | 001-38560 | 241353073 | 33 | 297694 | |||
| 2024-10-01 | SC 13D/A | SC 13D/A | 0001193125-24-230376 | 005-83932 | 241344574 | 34 | 33358 | |||
| 2024-09-30 | 8-K | 8-K | 8.01 | 0001193125-24-228322 | 001-38560 | 241336460 | 34 | 143145 | 1 | 1 |
| 2024-09-19 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-222116 | 001-38560 | 241310561 | 34 | 181946 | 1 | 1 |
| 2024-09-05 | 4 | xslF345X05/form4-09052024_090938.xml | 0001415889-24-022964 | 6980 | ||||||
| 2024-09-03 | SC 13G | aadi.htm | 0000935836-24-000579 | 005-83932 | 241275295 | 34 | 48107 | |||
| 2024-09-03 | 144 | xsl144X01/primary_doc.xml | 0001949846-24-000526 | 001-38560 | 241272589 | 33 | 7623 | |||
| 2024-08-28 | SC 13G | aadi13g.htm | 0001373604-24-000079 | 005-83932 | 241256086 | 34 | 76706 | |||
| 2024-08-22 | 8-K | 8-K | 5.02 | 0001193125-24-205370 | 001-38560 | 241232180 | 34 | 144655 | 1 | 1 |
| 2024-08-21 | 8-K | 8-K | 2.05,8.01,9.01 | 0001193125-24-203889 | 001-38560 | 241227010 | 34 | 167272 | 1 | 1 |
| 2024-08-07 | 10-Q | 10-Q | 0001628280-24-035636 | 001-38560 | 241184035 | 34 | 7394570 | 1 | 1 | |
| 2024-08-07 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-035390 | 001-38560 | 241181514 | 34 | 267771 | 1 | 1 |
| 2024-08-05 | 4 | xslF345X05/form4-08052024_100800.xml | 0001415889-24-020784 | 10982 | ||||||
| 2024-07-02 | 4 | xslF345X05/form4-07022024_100754.xml | 0001415889-24-019045 | 8982 | ||||||
| 2024-06-14 | 4 | xslF345X05/form4-06142024_080636.xml | 0001415889-24-016874 | 10360 | ||||||
| 2024-06-14 | 4 | xslF345X05/form4-06142024_080605.xml | 0001415889-24-016873 | 5994 | ||||||
| 2024-06-14 | 4 | xslF345X05/form4-06142024_080614.xml | 0001415889-24-016872 | 5981 | ||||||
| 2024-06-14 | 4 | xslF345X05/form4-06142024_080619.xml | 0001415889-24-016870 | 5969 | ||||||
| 2024-06-14 | 4 | xslF345X05/form4-06142024_080632.xml | 0001415889-24-016868 | 5986 | ||||||
| 2024-06-14 | 4 | xslF345X05/form4-06142024_080626.xml | 0001415889-24-016865 | 5941 | ||||||
| 2024-06-14 | 4 | xslF345X05/form4-06142024_080653.xml | 0001415889-24-016862 | 5999 | ||||||
| 2024-06-12 | 8-K | 8-K | 5.07 | 0001628280-24-027826 | 001-38560 | 241038638 | 34 | 165241 | 1 | 1 |
| 2024-06-05 | 4 | xslF345X05/form4-06052024_080618.xml | 0001415889-24-015561 | 8982 | ||||||
| 2024-06-03 | 144 | xsl144X01/primary_doc.xml | 0001949846-24-000316 | 001-38560 | 241012766 | 33 | 6438 | |||
| 2024-05-08 | 10-Q | 10-Q | 0001628280-24-021657 | 001-38560 | 24925859 | 34 | 6959101 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-021381 | 001-38560 | 24924335 | 34 | 254712 | 1 | 1 |
| 2024-05-03 | 424B5 | 424B5 | 0001193125-24-130684 | 333-277018 | 24913009 | 33 | 224069 | |||
| 2024-05-01 | 4 | xslF345X05/form4-05022024_120534.xml | 0001415889-24-011937 | 6981 | ||||||
| 2024-04-30 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-04-30 16:00:00 | 9999999995-24-001211 | 333-277018 | 24899795 | 33 | 1982 | ||
| 2024-04-26 | CORRESP | filename1.htm | 0001193125-24-118308 | 7559 | ||||||
| 2024-04-26 | ARS | ARS | 0001193125-24-118295 | 001-38560 | 24884837 | 34 | 14263245 | |||
| 2024-04-26 | 3 | xslF345X02/form3-04262024_080448.xml | 0001415889-24-011595 | 16578 | ||||||
| 2024-04-26 | DEFA14A | DEFA14A | 0001628280-24-018548 | 001-38560 | 24882224 | 34 | 1257947 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0001628280-24-018546 | 001-38560 | 24882211 | 34 | 3601411 | 1 | 1 | |
| 2024-04-04 | 8-K | 8-K | 1.01 | 0001628280-24-014876 | 001-38560 | 24823213 | 34 | 150102 | 1 | 1 |
| 2024-04-03 | 4 | xslF345X05/form4-04032024_080413.xml | 0001415889-24-010037 | 8982 | ||||||
| 2024-03-13 | 10-K | 10-K | 0001628280-24-010901 | 001-38560 | 24746189 | 34 | 12558254 | 1 | 1 | |
| 2024-03-13 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-010791 | 001-38560 | 24744637 | 34 | 281014 | 1 | 1 |
| 2024-03-04 | 4 | xslF345X05/form4-03052024_120319.xml | 0001415889-24-006421 | 8983 | ||||||
| 2024-03-04 | 4 | xslF345X05/form4-03052024_120358.xml | 0001415889-24-006416 | 11331 | ||||||
| 2024-03-04 | 4 | xslF345X05/form4-03052024_120318.xml | 0001415889-24-006414 | 11497 | ||||||
| 2024-03-04 | 4 | xslF345X05/form4-03052024_120310.xml | 0001415889-24-006411 | 11463 | ||||||
| 2024-03-01 | 144 | xsl144X01/primary_doc.xml | 0001949846-24-000105 | 001-38560 | 24708489 | 33 | 99504 | |||
| 2024-02-20 | UPLOAD | filename1.pdf | 0000000000-24-001932 | 333-277018 | 40537 | |||||
| 2024-02-12 | S-8 | S-8 | 0001193125-24-032285 | 333-277020 | 24621341 | 33 | 96983 | |||
| 2024-02-12 | S-3 | S-3 | 0001193125-24-032274 | 333-277018 | 24621267 | 33 | 636478 | |||
| 2024-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-24-002684 | 7142 | ||||||
| 2024-01-02 | 4 | FORM 4 SUBMISSION | 0001209191-24-000254 | 7142 | ||||||
| 2023-12-14 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-295566 | 001-38560 | 231487866 | 34 | 2458770 | 1 | 1 |
| 2023-12-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-057713 | 7059 | ||||||
| 2023-12-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-057545 | 11387 | ||||||
| 2023-12-01 | 144 | xsl144X01/primary_doc.xml | 0001949846-23-000458 | 001-38560 | 231458120 | 33 | 8163 | |||
| 2023-11-08 | 10-Q | 10-Q | 0001628280-23-037905 | 001-38560 | 231388962 | 34 | 7292126 | 1 | 1 | |
| 2023-11-08 | 8-K/A | 8-K/A | 2.02,9.01 | 0001628280-23-037882 | 001-38560 | 231388317 | 34 | 283592 | 1 | 1 |
| 2023-11-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-037568 | 001-38560 | 231386046 | 34 | 166992 | 1 | 1 |
| 2023-11-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-054214 | 9225 | ||||||
| 2023-10-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-051697 | 9224 | ||||||
| 2023-10-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-051695 | 8793 | ||||||
| 2023-10-03 | 3 | FORM 3 SUBMISSION | 0001209191-23-051694 | 5355 | ||||||
| 2023-10-02 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-23-248461 | 001-38560 | 231298013 | 34 | 553786 | 1 | 1 |
| 2023-09-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-048535 | 11385 | ||||||
| 2023-09-01 | 144 | xsl144X01/primary_doc.xml | 0001949846-23-000307 | 001-38560 | 231231344 | 33 | 8760 | |||
| 2023-08-09 | 10-Q | 10-Q | 0001628280-23-028562 | 001-38560 | 231155133 | 34 | 7034935 | 1 | 1 | |
| 2023-08-09 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-028411 | 001-38560 | 231153441 | 34 | 287509 | 1 | 1 |
| 2023-08-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-044439 | 9222 | ||||||
| 2023-07-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-041700 | 11389 | ||||||
| 2023-07-03 | 144 | xsl144X01/primary_doc.xml | 0001949846-23-000177 | 001-38560 | 231064133 | 33 | 213549 | |||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038675 | 10150 | ||||||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038665 | 5913 | ||||||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038664 | 5921 | ||||||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038663 | 5896 | ||||||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038662 | 5868 | ||||||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038661 | 5926 | ||||||
| 2023-06-16 | 8-K | 8-K | 5.07 | 0001628280-23-022421 | 001-38560 | 231020663 | 34 | 195111 | 1 | 1 |
| 2023-06-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-034888 | 7058 | ||||||
| 2023-06-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-034632 | 11384 | ||||||
| 2023-05-10 | 10-Q | 10-Q | 0001628280-23-017234 | 001-38560 | 23906551 | 34 | 7054669 | 1 | 1 | |
| 2023-05-10 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-017031 | 001-38560 | 23904425 | 34 | 288829 | 1 | 1 |
| 2023-05-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-027672 | 7058 | ||||||
| 2023-05-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-027161 | 11383 | ||||||
| 2023-04-28 | ARS | ARS | 0001193125-23-125869 | 001-38560 | 23863464 | 34 | 8946420 | |||
| 2023-04-28 | DEFA14A | DEFA14A | 0001628280-23-014004 | 001-38560 | 23863054 | 34 | 619436 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0001628280-23-014000 | 001-38560 | 23863003 | 34 | 3938846 | 1 | 1 | |
| 2023-04-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-023692 | 7060 | ||||||
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-023483 | 11380 | ||||||
| 2023-04-04 | 4 | FORM 4 SUBMISSION | 0001209191-23-022657 | 6226 | ||||||
| 2023-04-03 | 144 | xsl144X01/primary_doc.xml | 0001949846-23-000022 | 001-38560 | 23791851 | 33 | 4484 | |||
| 2023-03-29 | 4 | FORM 4 SUBMISSION | 0001209191-23-021531 | 5979 | ||||||
| 2023-03-29 | 3 | FORM 3 SUBMISSION | 0001209191-23-021530 | 5286 | ||||||
| 2023-03-29 | S-8 | S-8 | 0001193125-23-083652 | 333-270933 | 23775252 | 33 | 88816 | |||
| 2023-03-29 | 10-K | 10-K | 0001628280-23-009583 | 001-38560 | 23770824 | 34 | 32045386 | 1 | 1 | |
| 2023-03-28 | 8-K/A | 8-K/A | 5.02 | 0001193125-23-082149 | 001-38560 | 23769569 | 34 | 149470 | 1 | 1 |
| 2023-03-28 | 8-K | 8-K | 2.02,5.02,9.01 | 0001628280-23-009345 | 001-38560 | 23766272 | 34 | 340781 | 1 | 1 |
| 2023-03-03 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-23-059077 | 001-38560 | 23701740 | 34 | 179576 | 1 | 1 |
| 2023-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-014615 | 6057 | ||||||
| 2023-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-014603 | 6183 | ||||||
| 2023-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-014589 | 6188 | ||||||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-23-010884 | 005-83932 | 23620328 | 34 | 74467 | |||
| 2023-02-10 | SC 13G/A | ff1723252_13ga1-satter.htm | 0000895345-23-000071 | 005-83932 | 23610067 | 34 | 59916 | |||
| 2023-01-23 | 8-K | 8-K | 1.01 | 0001193125-23-012507 | 001-38560 | 23542460 | 34 | 145238 | 1 | 1 |
| 2023-01-17 | SC 13D/A | SC 13D/A | 0001193125-23-009518 | 005-83932 | 23532095 | 34 | 50857 | |||
| 2023-01-04 | 4 | FORM 4 SUBMISSION | 0001209191-23-000857 | 6190 | ||||||
| 2023-01-04 | 4 | FORM 4 SUBMISSION | 0001209191-23-000843 | 6203 | ||||||
| 2022-12-07 | 8-K | 8-K | 5.03,9.01 | 0001193125-22-300219 | 001-38560 | 221450792 | 34 | 367746 | 1 | 1 |
| 2022-11-28 | 8-K | 8-K | 3.01 | 0001193125-22-292703 | 001-38560 | 221420955 | 34 | 146119 | 1 | 1 |
| 2022-11-09 | 10-Q | 10-Q | 0001628280-22-029228 | 001-38560 | 221372695 | 34 | 7828002 | 1 | 1 | |
| 2022-11-09 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-22-280757 | 001-38560 | 221370762 | 34 | 296169 | 1 | 1 |
| 2022-11-04 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-11-04 16:00:00 | 9999999995-22-003214 | 333-268021 | 221363523 | 33 | 1934 | ||
| 2022-11-04 | 424B3 | 424B3 | 0001193125-22-277880 | 333-268021 | 221362311 | 33 | 175052 | |||
| 2022-11-02 | CORRESP | filename1.htm | 0001193125-22-275811 | 8139 | ||||||
| 2022-11-01 | UPLOAD | filename1.pdf | 0000000000-22-011922 | 40403 | ||||||
| 2022-10-26 | S-3 | S-3 | 0001193125-22-269638 | 333-268021 | 221333814 | 33 | 301205 | |||
| 2022-10-11 | D | xslFormDX01/primary_doc.xml | 06b | 0001209191-22-053234 | 021-461325 | 221303300 | 33 | 13980 | ||
| 2022-10-04 | SC 13G | ff1376291_13g-satter.htm | 0000895345-22-000734 | 005-83932 | 221291389 | 34 | 60048 | |||
| 2022-09-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-051391 | 5749 | ||||||
| 2022-09-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-051390 | 6245 | ||||||
| 2022-09-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-051389 | 4757 | ||||||
| 2022-09-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-051388 | 4780 | ||||||
| 2022-09-26 | 4 | xslF345X03/ownership.xml | 0000902664-22-004356 | 9931 | ||||||
| 2022-09-26 | SC 13D/A | AADI BIOSCIENCE, INC. | 0000902664-22-004355 | 005-83932 | 221266815 | 34 | 76555 | |||
| 2022-09-22 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-22-249235 | 001-38560 | 221259667 | 34 | 651231 | 1 | 1 |
| 2022-08-10 | 10-Q | 10-Q | 0001628280-22-022208 | 001-38560 | 221151852 | 34 | 6656652 | 1 | 1 | |
| 2022-08-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-216844 | 001-38560 | 221150501 | 34 | 254433 | 1 | 1 |
| 2022-06-30 | 8-K | 8-K | 1.02 | 0001193125-22-185324 | 001-38560 | 221056302 | 34 | 148772 | 1 | 1 |
| 2022-06-17 | 8-K | 8-K | 5.07 | 0001193125-22-176646 | 001-38560 | 221025086 | 34 | 155322 | 1 | 1 |
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-037893 | 7994 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-037888 | 8027 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-037883 | 8038 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-037874 | 7970 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-037866 | 8021 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-037859 | 12485 | ||||||
| 2022-05-12 | 10-Q | 10-Q | 0001564590-22-019856 | 001-38560 | 22917866 | 34 | 9929037 | 1 | 1 | |
| 2022-05-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-148067 | 001-38560 | 22915698 | 34 | 256472 | 1 | 1 |
| 2022-04-26 | DEFA14A | DEFA14A | 0001193125-22-119049 | 001-38560 | 22851919 | 34 | 120321 | |||
| 2022-04-26 | DEF 14A | DEF 14A | 0001564590-22-015513 | 001-38560 | 22851785 | 34 | 1070842 | |||
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-023352 | 8268 | ||||||
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-023351 | 8158 | ||||||
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-023350 | 8249 | ||||||
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-023349 | 8316 | ||||||
| 2022-03-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-020582 | 9036 | ||||||
| 2022-03-21 | 424B5 | 424B5 | 0001193125-22-079762 | 333-255129 | 22754106 | 33 | 491795 | |||
| 2022-03-17 | 424B5 | 424B5 | 0001193125-22-078485 | 333-259785 | 22750011 | 33 | 490728 | |||
| 2022-03-17 | 8-K | 8-K | 1.01,9.01 | 0001193125-22-078484 | 001-38560 | 22750003 | 34 | 405462 | 1 | 1 |
| 2022-03-17 | S-8 | S-8 | 0001193125-22-078324 | 333-263639 | 22748765 | 33 | 77910 | |||
| 2022-03-17 | 10-K | 10-K | 0001564590-22-010721 | 001-38560 | 22746820 | 34 | 13767455 | 1 | 1 | |
| 2022-03-17 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-077792 | 001-38560 | 22746711 | 34 | 285365 | 1 | 1 |
| 2022-02-14 | SC 13G | SC 13G | 0001104659-22-022801 | 005-83932 | 22631995 | 34 | 269455 | |||
| 2022-02-14 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-22-000440 | 005-83932 | 22623844 | 34 | 277161 | |||
| 2022-02-11 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-22-007078 | 005-83932 | 22622785 | 34 | 65551 | |||
| 2022-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-016347 | 005-83932 | 22606205 | 34 | 13187 | |||
| 2022-01-20 | 8-K | 8-K | 1.01 | 0001193125-22-012763 | 001-38560 | 22540530 | 34 | 146669 | 1 | 1 |
| 2021-11-29 | 3 | FORM 3 SUBMISSION | 0000899243-21-046210 | 7565 | ||||||
| 2021-11-23 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-337294 | 001-38560 | 211434644 | 34 | 217032 | 1 | 1 |
| 2021-11-15 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-139237 | 005-83932 | 211411422 | 34 | 80296 | |||
| 2021-11-12 | SC 13D/A | SC 13D/A | 0001193125-21-328045 | 005-83932 | 211403286 | 34 | 30703 | |||
| 2021-11-10 | 10-Q | 10-Q | 0001564590-21-055958 | 001-38560 | 211394643 | 34 | 12681360 | 1 | 1 | |
| 2021-11-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-325243 | 001-38560 | 211394384 | 34 | 259180 | 1 | 1 |
| 2021-11-01 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-21-315472 | 001-38560 | 211367585 | 34 | 182811 | 1 | 1 |
| 2021-10-25 | 4 | FORM 4 SUBMISSION | 0000899243-21-041483 | 6063 | ||||||
| 2021-10-25 | 3 | FORM 3 SUBMISSION | 0000899243-21-041480 | 6471 | ||||||
| 2021-10-04 | 424B3 | 424B3 | 0001193125-21-289952 | 333-259785 | 211300313 | 33 | 246984 | |||
| 2021-10-01 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-10-01 16:00:00 | 9999999995-21-003752 | 333-259785 | 211300890 | 33 | 1934 | ||
| 2021-09-30 | CORRESP | filename1.htm | 0001193125-21-287949 | 7770 | ||||||
| 2021-09-29 | UPLOAD | filename1.pdf | 0000000000-21-011837 | 40413 | ||||||
| 2021-09-24 | S-8 | S-8 | 0001193125-21-282449 | 333-259787 | 211278017 | 33 | 96625 | |||
| 2021-09-24 | S-3 | S-3 | 0001193125-21-282440 | 333-259785 | 211277978 | 33 | 341962 | |||
| 2021-09-24 | 8-K/A | 8-K/A | 9.01 | 0001193125-21-282412 | 001-38560 | 211277877 | 34 | 1184964 | 1 | 1 |
| 2021-09-22 | 4 | FORM 4 SUBMISSION | 0000899243-21-037065 | 6171 | ||||||
| 2021-09-22 | 3 | FORM 3 SUBMISSION | 0000899243-21-037063 | 5739 | ||||||
| 2021-09-20 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-21-276826 | 001-38560 | 211262195 | 34 | 264367 | 1 | 1 |
| 2021-09-13 | 8-K | 8-K | 4.01,5.02,9.01 | 0001193125-21-270953 | 001-38560 | 211248701 | 34 | 182733 | 1 | 1 |
| 2021-09-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-035568 | 6241 | ||||||
| 2021-09-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-035558 | 6025 | ||||||
| 2021-09-10 | 3 | FORM 3 SUBMISSION | 0000899243-21-035554 | 5624 | ||||||
| 2021-09-10 | D | xslFormDX01/primary_doc.xml | 06b | 0001209191-21-055406 | 021-412879 | 211245700 | 33 | 15187 | ||
| 2021-09-10 | D | xslFormDX01/primary_doc.xml | 06b | 0001209191-21-055401 | 021-412878 | 211245695 | 33 | 13669 | ||
| 2021-09-08 | SC 13D | SC 13D | 0001193125-21-267979 | 005-83932 | 211243019 | 34 | 47665 | |||
| 2021-09-07 | SC 13G | sc13g07422010_09072021.htm | 0000921895-21-002248 | 005-83932 | 211240124 | 34 | 285226 | |||
| 2021-09-07 | SC 13D | AADI BIOSCIENCE, INC. | 0001104659-21-113485 | 005-83932 | 211240117 | 34 | 68010 | |||
| 2021-09-03 | 8-K | 8-K | 1.01 | 0001193125-21-265609 | 001-38560 | 211237219 | 34 | 154027 | 1 | 1 |
| 2021-09-03 | SC 13D/A | AMENDMENT NO. 3 | 0000947871-21-000981 | 005-83932 | 211237127 | 34 | 88739 | |||
| 2021-09-02 | SC 13G | SCHEDULE 13G | 0001213900-21-046399 | 005-83932 | 211233634 | 34 | 72450 | |||
| 2021-08-31 | 4 | FORM 4 SUBMISSION | 0000899243-21-034657 | 5914 | ||||||
| 2021-08-31 | 4 | FORM 4 SUBMISSION | 0000899243-21-034655 | 5854 | ||||||
| 2021-08-31 | 3 | FORM 3 SUBMISSION | 0000899243-21-034651 | 5732 | ||||||
| 2021-08-31 | 3 | FORM 3 SUBMISSION | 0000899243-21-034650 | 5617 | ||||||
| 2021-08-31 | 3 | FORM 3 SUBMISSION | 0000899243-21-034649 | 8511 | ||||||
| 2021-08-31 | 3 | FORM 3 SUBMISSION | 0000899243-21-034646 | 11156 | ||||||
| 2021-08-31 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-034635 | 5931 | ||||||
| 2021-08-30 | 4 | FORM 4 SUBMISSION | 0000899243-21-034553 | 9500 | ||||||
| 2021-08-30 | 4 | FORM 4 SUBMISSION | 0000899243-21-034546 | 11970 | ||||||
| 2021-08-30 | 4 | xslF345X03/ownership.xml | 0000902664-21-004071 | 13266 | ||||||
| 2021-08-30 | 3 | xslF345X02/ownership.xml | 0000902664-21-004070 | 8735 | ||||||
| 2021-08-30 | SC 13D/A | AADI BIOSCIENCE, INC. | 0000902664-21-004068 | 005-83932 | 211224624 | 34 | 83757 | |||
| 2021-08-27 | 8-K | 8-K | 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,9.01 | 0001193125-21-257910 | 001-38560 | 211213959 | 34 | 11999730 | 1 | 1 |
| 2021-08-23 | 8-K | 8-K | 1.01,9.01 | 0001193125-21-254142 | 001-38560 | 211197845 | 34 | 878057 | 1 | 1 |
| 2021-08-23 | SC 13G | AERPIO PHARMACEUTICALS, INC. | 0001104659-21-108584 | 005-83932 | 211197337 | 34 | 76881 | |||
| 2021-08-18 | 8-K | 8-K | 5.07 | 0001193125-21-249389 | 001-38560 | 211184498 | 34 | 162805 | 1 | 1 |
| 2021-08-11 | 10-Q | 10-Q | 0001564590-21-043488 | 001-38560 | 211164133 | 34 | 6355774 | 1 | 1 | |
| 2021-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-243396 | 001-38560 | 211163686 | 34 | 88585 | ||
| 2021-07-26 | 8-K | 8-K | 5.07,7.01,9.01 | 0001193125-21-223693 | 001-38560 | 211112493 | 34 | 39780 | ||
| 2021-07-12 | SC 13G | AERPIO PHARMACEUTICALS, INC. | 0001104659-21-091191 | 005-83932 | 211085843 | 34 | 85242 | |||
| 2021-07-08 | DEFM14A | DEFM14A | 0001193125-21-210402 | 001-38560 | 211079095 | 34 | 7198113 | |||
| 2021-07-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-027291 | 5013 | ||||||
| 2021-07-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-027290 | 5003 | ||||||
| 2021-07-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-027289 | 5044 | ||||||
| 2021-07-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-027286 | 5059 | ||||||
| 2021-07-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-027281 | 5043 | ||||||
| 2021-06-22 | 4 | FORM 4 SUBMISSION | 0000899243-21-025336 | 5273 | ||||||
| 2021-06-21 | PREM14A | PREM14A | 0001193125-21-194158 | 001-38560 | 211027408 | 34 | 7240036 | |||
| 2021-06-09 | DEFA14A | DEFA14A | 0001193125-21-186104 | 001-38560 | 211004089 | 34 | 126418 | |||
| 2021-06-09 | DEF 14A | DEF 14A | 0001564590-21-032185 | 001-38560 | 211004086 | 34 | 1053061 | |||
| 2021-06-04 | DEFA14A | DEFA14A | 0001193125-21-182391 | 001-38560 | 21995185 | 34 | 64615 | |||
| 2021-06-04 | 8-K | 8-K | 7.01,9.01 | 0001193125-21-182386 | 001-38560 | 21995182 | 34 | 52361 | ||
| 2021-06-04 | SC 13D | AERPIO PHARMACEUTICALS, INC. | 0000902664-21-003006 | 005-83932 | 21994979 | 34 | 76069 | |||
| 2021-05-26 | SC 13G | SCHEDULE 13G | 0000899140-21-000513 | 005-83932 | 21967199 | 34 | 44509 | |||
| 2021-05-20 | DEFA14A | DEFA14A | 0001193125-21-167187 | 001-38560 | 21942344 | 34 | 62713 | |||
| 2021-05-20 | 8-K | 8-K | 7.01,9.01 | 0001193125-21-167180 | 001-38560 | 21942332 | 34 | 50249 | ||
| 2021-05-17 | 10-Q | 10-Q | 0001564590-21-028204 | 001-38560 | 21927887 | 34 | 4609735 | 1 | ||
| 2021-05-17 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-162826 | 001-38560 | 21927694 | 34 | 76247 | ||
| 2021-05-17 | 8-K | 8-K | 1.01,3.02,5.01,5.02,5.03,7.01,9.01 | 0001193125-21-162770 | 001-38560 | 21927579 | 34 | 1372282 | ||
| 2021-05-17 | DEFA14A | 8-K | 0001193125-21-162772 | 001-38560 | 21927569 | 34 | 1371730 | |||
| 2021-04-15 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-04-15 16:01:00 | 9999999995-21-001458 | 333-255129 | 21829993 | 33 | 1776 | ||
| 2021-04-13 | CORRESP | filename1.htm | 0001193125-21-114919 | 7722 | ||||||
| 2021-04-12 | UPLOAD | filename1.pdf | 0000000000-21-004405 | 40220 | ||||||
| 2021-04-08 | S-3 | S-3 | 0001564590-21-018182 | 333-255129 | 21815230 | 33 | 2090902 | |||
| 2021-04-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-014676 | 5043 | ||||||
| 2021-04-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-014675 | 5013 | ||||||
| 2021-04-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-014674 | 5044 | ||||||
| 2021-04-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-014672 | 5004 | ||||||
| 2021-04-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-014673 | 5060 | ||||||
| 2021-04-01 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-104183 | 001-38560 | 21799317 | 34 | 89195 | ||
| 2021-03-11 | 10-K | 10-K | 0001564590-21-012252 | 001-38560 | 21731918 | 34 | 7756752 | 1 | ||
| 2021-03-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-077108 | 001-38560 | 21731906 | 34 | 86635 | ||
| 2021-03-05 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-070454 | 001-38560 | 21716586 | 34 | 49147 | ||
| 2021-02-16 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-044954 | 001-38560 | 21639148 | 34 | 65719 | ||
| 2021-02-10 | SC 13G/A | NONE | 0001567619-21-002778 | 005-83932 | 21613446 | 34 | 82519 | |||
| 2021-02-10 | SC 13G | SCHEDULE 13G | 0001104659-21-017352 | 005-83932 | 21609908 | 34 | 13864 | |||
| 2021-02-03 | 4 | FORM 4 SUBMISSION | 0000899243-21-004896 | 5328 | ||||||
| 2021-02-03 | 4 | FORM 4 SUBMISSION | 0000899243-21-004893 | 5327 | ||||||
| 2021-02-03 | 4 | FORM 4 SUBMISSION | 0000899243-21-004891 | 5342 | ||||||
| 2021-02-03 | 4 | FORM 4 SUBMISSION | 0000899243-21-004890 | 5297 | ||||||
| 2021-02-01 | 8-K | 8-K | 2.05,5.02,9.01 | 0001193125-21-024764 | 001-38560 | 21577843 | 34 | 43251 | ||
| 2021-01-11 | SC 13G | SC 13G | 0001193125-21-005470 | 005-83932 | 21518943 | 34 | 120424 | |||
| 2021-01-05 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-001953 | 001-38560 | 21505544 | 34 | 41277 | ||
| 2020-12-11 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-315989 | 001-38560 | 201384326 | 34 | 39960 | ||
| 2020-12-10 | 4 | xslF345X03/ownership.xml | 0000947871-20-000944 | 13926 | ||||||
| 2020-11-23 | SC 13D/A | SC 13D/A | 0001193125-20-299536 | 005-83932 | 201333579 | 34 | 28739 |
One latest value per concept from companyfacts (362 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 59.01M | 2026-11-05 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 64.90M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 2.59M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001193125-26-187149 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.96M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001193125-26-187149 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 4.49M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001193125-26-187149 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 3.40M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001193125-26-187149 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 18.86 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001193125-26-187149 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 13,995.24 | 2026-05-28 | S-3 | 2026-05-29 | 0001193125-26-248349 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 13,995.24 | 2026-05-28 | S-3 | 2026-05-29 | 0001193125-26-248349 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 101.34M | 2026-05-28 | S-3 | 2026-05-29 | 0001193125-26-248349 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-28 | S-3 | 2026-05-29 | 0001193125-26-248349 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-05-28 | S-3 | 2026-05-29 | 0001193125-26-248349 | |||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 2.20M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 2.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 1.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 2.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 8.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 548,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 1.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AccruedVacationCurrent | Accrued Vacation, Current | USD | 31,701 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 376,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -216,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 49,500 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001213900-17-002066 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 576.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | USD | 13.45M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006602 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 1.75M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 402,795 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012252 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 9,592 | 2020-04-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 |
| us-gaap | AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables | Allowance for Doubtful Accounts, Premiums and Other Receivables | USD | 100,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableWriteOffs | Accounts Receivable, Allowance for Credit Loss, Writeoff | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | -1.20M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001628280-23-017234 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 75,561 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006602 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | -3.14M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010901 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010901 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 2.06M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 |
| us-gaap | Assets | Assets | USD | 173.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 171.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 3,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 219,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 169.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedLoss | Debt Securities, Available-for-sale, Unrealized Loss | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001193125-26-212075 |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 169.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 68.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -14.46M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-08 | 0001564590-19-030747 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 169.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 68.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 31.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 7.29 | 2019-10-31 | 2024 | FY | 10-K | 2025-03-28 | 0001628280-25-015269 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 40,000 | 2019-10-31 | 2024 | FY | 10-K | 2025-03-28 | 0001628280-25-015269 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 29,167 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001628280-25-015269 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 59.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 59.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 5,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -60.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 18.67M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-14 | 0001564590-18-021632 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 74.70M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006602 |
| us-gaap | ConvertibleDebtFairValueDisclosures | Convertible Debt, Fair Value Disclosures | USD | 9.50M | 2021-08-26 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 | |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 1.10M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 | |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 9.03M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 64.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 9,000 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0001628280-22-022208 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | DebtConversionConvertedInstrumentSharesIssued1 | Debt Conversion, Converted Instrument, Shares Issued | shares | 698,018 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 4.8 | 2021-05-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 | |
| us-gaap | DebtInstrumentInterestRateDuringPeriod | Debt Instrument, Interest Rate During Period | pure | 0.06 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001213900-17-002066 |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 5,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax | USD | -8,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001628280-24-021657 | |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 200,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedLoss | Debt Securities, Available-for-sale, Realized Loss | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 96.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 115,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | DeferredRentCreditCurrent | Deferred Rent Credit, Current | USD | 31,042 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-15 | 0001564590-18-013535 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 44.69M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 3.34M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | DeferredTaxAssetsInvestmentInSubsidiaries | Deferred Tax Assets, Investment in Subsidiaries | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 115,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 26.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 3.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 1.11M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 428,125 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012252 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 107,525 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012252 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 44.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 115,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 17,425 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012252 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 400,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012252 |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 20,000 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 | |
| us-gaap | Depreciation | Depreciation | USD | 2,400 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 79,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 205,041 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001213900-15-001427 | |
| us-gaap | DividendsCommonStockCash | Dividends, Common Stock, Cash | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 258,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 | |
| us-gaap | DueToRelatedPartiesNoncurrent | Due to Related Parties, Noncurrent | USD | 5.76M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.73 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.66 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.73 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 3.304 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0.215 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary | Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent | pure | -0.536 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent | pure | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.045 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.022 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012252 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.107 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.071 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 9.90M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001628280-25-015269 | |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 | |
| us-gaap | FairValueLiabilitiesLevel1ToLevel2TransfersAmount | Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 | |
| us-gaap | FairValueLiabilitiesLevel2ToLevel1TransfersAmount | Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 87,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0001628280-22-029228 | |
| us-gaap | FinitelivedIntangibleAssetsAcquired1 | Finite-lived Intangible Assets Acquired | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 2.45M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 273,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | USD | 205,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 273,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 273,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 273,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 273,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 | |
| us-gaap | FiniteLivedIntangibleAssetsFairValueDisclosure | Finite-lived Intangible Assets, Fair Value Disclosure | USD | 3.90M | 2021-08-26 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010901 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 3.81M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0001628280-22-029228 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 0 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010901 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | -9,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -93,285 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 |
| us-gaap | GainLossOnSaleOfBusiness | Gain (Loss) on Disposition of Business | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 18.51M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 |
| us-gaap | ImpairmentOfIntangibleAssetsExcludingGoodwill | Impairment of Intangible Assets (Excluding Goodwill) | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001628280-23-037905 |
| us-gaap | ImpairmentOfIntangibleAssetsFinitelived | Impairment of Intangible Assets, Finite-lived | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010901 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -60.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 9,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0001628280-22-029228 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001628280-23-037905 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperations | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-28 | 0001144204-13-018033 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -68.05M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | -4.43M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -4.33M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | -6,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 925,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 100 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001213900-17-002066 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 2.21M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 1.47M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 600 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001213900-17-002066 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -4.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities | Increase (Decrease) in Accounts Payable and Other Operating Liabilities | USD | -817,121 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-052756 |
| us-gaap | IncreaseDecreaseInAccountsPayableRelatedParties | Increase (Decrease) in Accounts Payable, Related Parties | USD | -8.38M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | IncreaseDecreaseInAccruedInterestReceivableNet | Increase (Decrease) in Accrued Interest Receivable, Net | USD | -7,371 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-14 | 0001213900-16-018356 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 4,375 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001213900-17-002066 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 18.67M | 2018-01-01 | 2018-06-30 | 2019 | Q2 | 10-Q | 2019-08-08 | 0001564590-19-030747 |
| us-gaap | IncreaseDecreaseInDepositOtherAssets | Increase (Decrease) in Deposit Assets | USD | -20,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012252 |
| us-gaap | IncreaseDecreaseInDeposits | Increase (Decrease) in Deposits | USD | -20,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006602 |
| us-gaap | IncreaseDecreaseInInterestPayableNet | Increase (Decrease) in Interest Payable, Net | USD | 9,942 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001213900-17-002066 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -12,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | IncreaseDecreaseInOtherAccruedLiabilities | Increase (Decrease) in Other Accrued Liabilities | USD | 1,500 | 2007-11-16 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-15 | 0001144204-12-029112 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | -1.03M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -439,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 394,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001628280-24-045698 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -2.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | -2,500 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001213900-16-012024 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 | |
| us-gaap | InterestExpense | Interest Expense | USD | 58,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001628280-24-021657 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | InterestExpenseRelatedParty | Interest Expense, Related Party | USD | 600,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 5,707 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 483,442 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001564590-18-005868 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | InventoryRawMaterialsAndSupplies | Inventory, Raw Materials and Supplies, Gross | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 4.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.077 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001628280-25-015269 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 228,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 110,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 140,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 109,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010901 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 109,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001628280-25-015269 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 280,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001628280-25-015269 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 54,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 34,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 10,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | Liabilities | Liabilities | USD | 10.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 173.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 10.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | LiabilityForUncertainTaxPositionsCurrent | Liability for Uncertainty in Income Taxes, Current | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 | |
| us-gaap | LossContingencyAccrualAtCarryingValue | Loss Contingency Accrual | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 81.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 21,992 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-15 | 0001564590-18-013535 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 6.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -8,498 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-15 | 0001564590-18-013535 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -56.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -6.51M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-15 | 0001564590-18-013535 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -60.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -60.51M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -60.51M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 1.52M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 |
| us-gaap | NotesPayableRelatedPartiesClassifiedCurrent | Notes Payable, Related Parties, Current | USD | 170,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001213900-17-002066 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 112.34M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -64.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 113,429 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012252 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 87,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 218,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 130,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 88,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 212,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 344,779 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001564590-18-028092 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 257,050 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006602 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 239,781 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006602 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 31,653 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001564590-18-028092 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 183,222 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006602 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.133 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012252 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 42,400 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001213900-17-002066 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 110,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 578,461 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 1.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | -15,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-08 | 0001628280-25-023932 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -99,000 | 2022-07-01 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001628280-23-037905 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -336,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 99,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 4.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | OtherPaymentsToAcquireBusinesses | Other Payments to Acquire Businesses | USD | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0001628280-22-022208 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 204,929 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006602 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 264,247 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001564590-18-005868 |
| us-gaap | PaymentsOfDividends | Payments of Dividends | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 120,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 5.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 105.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 3,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 145.19M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | PreferredStockRedemptionDiscount | Preferred Stock Redemption Discount | USD | 224,224 | 2016-01-01 | 2016-09-30 | 2017 | Q3 | 10-Q | 2017-11-13 | 0001564590-17-023441 |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 2.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 510,177 | 2020-12-31 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 297,354 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006602 |
| us-gaap | ProceedsFromDivestitureOfBusinessesNetOfCashDivested | Proceeds from Divestiture of Businesses, Net of Cash Divested | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 25.00M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 |
| us-gaap | ProceedsFromIssuanceOfUnsecuredDebt | Proceeds from Issuance of Unsecured Debt | USD | 10,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001213900-17-002066 |
| us-gaap | ProceedsFromLicenseFeesReceived | Proceeds from License Fees Received | USD | 15.00M | 2020-05-01 | 2020-05-31 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments | Proceeds from Maturities, Prepayments and Calls of Short-term Investments | USD | 111.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 120,000 | 2007-11-16 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-14 | 0001213900-13-004342 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 10,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-07 | 0001213900-17-002066 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 56,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 29,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010901 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | 402,346 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-052756 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 379,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 3,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits | Property Subject to or Available for Operating Lease, Number of Units | Property | 3 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006602 | |
| us-gaap | ProvisionForLoanAndLeaseLosses | Provision for Loan and Lease Losses | USD | 66,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 |
| us-gaap | PurchaseObligationDueInNextTwelveMonths | Purchase Obligation, to be Paid, Year One | USD | 2.70M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001628280-25-015269 | |
| us-gaap | PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear | Purchase Obligation, to be Paid, Remainder of Fiscal Year | USD | 4.40M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001628280-24-045698 | |
| us-gaap | ReclassificationsOfTemporaryToPermanentEquity | Reclassifications of Temporary to Permanent Equity | USD | 224,224 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001564590-18-005868 |
| us-gaap | RedeemableNoncontrollingInterestEquityPreferredCarryingAmount | Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount | USD | 73.76M | 2016-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001564590-18-005868 | |
| us-gaap | RelatedPartyCosts | Related Party Costs | USD | 578,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 |
| us-gaap | RelatedPartyTransactionAmountsOfTransaction | Related Party Transaction, Amounts of Transaction | USD | 1.40M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010721 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 10,000 | 2007-11-17 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001213900-15-001427 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 10,000 | 2007-11-16 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-15 | 0001144204-13-029407 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 48.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminated | Restructuring and Related Cost, Number of Positions Eliminated | Employee | 7 | 2021-01-01 | 2021-01-31 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.58 | 2021-01-01 | 2021-01-31 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 1.24M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -413.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 227,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 16.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 1.20M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 5.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost | Share-based Payment Arrangement, Accelerated Cost | USD | 300,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.847 | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.821 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.791 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.039 | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.049 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.037 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 41,394 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-17 | 0001564590-21-028204 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 4.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 5.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 8.71 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 48,700 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 518,706 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 796,199 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268895 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 10.9 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268895 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 41,539 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 4.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.85 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | USD/shares | 1.11 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-011174 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 10.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 12.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 5.44 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 4.47M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 419,036 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 8.26 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 10.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 12.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 5.44 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 1.69 | 2021-04-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 300,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | shares | 83,410 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-11 | 0001564590-21-043488 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 2.29 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 15.18 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 9.76 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 3.73 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 8.10M | 2021-08-26 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 100.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 163.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.067 | 2021-08-26 | 2024 | FY | 10-K | 2025-03-28 | 0001628280-25-015269 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 2.56M | 2021-08-26 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 24,286 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | -1,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0001628280-23-009583 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 28,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | -152,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 56,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | TemporaryEquityAccretionToRedemptionValueAdjustment | Temporary Equity, Accretion to Redemption Value, Adjustment | USD | 943,297 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006602 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 73.76M | 2016-12-31 | 2017 | Q2 | 10-Q | 2017-08-10 | 0001564590-17-017234 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 207,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 235,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-13 | 0001628280-24-010901 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued | Unrecognized Tax Benefits, Income Tax Penalties Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-11 | 0001564590-21-012252 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 290,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued | Unrecognized Tax Benefits, Interest on Income Taxes Accrued | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0001628280-25-015269 | |
| us-gaap | UnsecuredDebt | Unsecured Debt | USD | 15,000 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001213900-14-008152 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | -77.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104158 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 82.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 20.91M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019856 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 82.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453576 |